Hancock Whitney Corp purchased a new stake in Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,736 shares of the company’s stock, valued at approximately $263,000. Several other hedge funds and other institutional investors also […]
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) rose 5% during mid-day trading on Friday . The company traded as high as $18.34 and last traded at $18.33. Approximately 37,462 shares changed hands during trading, a decline of 97% from the average daily volume of 1,090,225 shares. The stock had previously closed at $17.46. […]
Shares of Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) have been assigned an average recommendation of “Moderate Buy” from the ten ratings firms that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price […]
Should You Buy or Sell Arcus Biosciences Stock? Get The Latest RCUS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
TheStreet upgraded shares of Arcus Biosciences (NYSE:RCUS – Get Rating) from a d rating to a c rating in a research note published on Monday, TheStreetRatingsTable reports. A number of other analysts have also commented on the stock. Truist Financial upped their price objective on shares of Arcus Biosciences from $70.00 to $77.00 in a […]